Female Hair Loss: A Different Challenge
Hair loss in women is fundamentally different from male pattern baldness — both in how it presents and in the complex web of causes that contribute to it. Yet it is no less distressing. For many women, hair is deeply intertwined with identity and confidence. Significant hair thinning can profoundly affect self-esteem, relationships, and quality of life.
Despite affecting an estimated 40% of women by age 40 and up to 55% of women over 70, female hair loss is chronically underdiagnosed. At Sapphire Roots, Dr. Ashwini takes a thorough, evidence-based approach — ordering comprehensive blood panels, performing detailed scalp examinations, and developing individualised treatment plans that address all contributing factors simultaneously.
Types of Female Hair Loss
Female Pattern Hair Loss (FPHL)
The most common form — the female equivalent of male pattern baldness. Unlike men, FPHL typically presents as diffuse thinning across the crown and top of the scalp, with relative preservation of the frontal hairline. Classified using the Ludwig Scale (Stages I–III).
Telogen Effluvium
The most common cause of sudden hair loss in women. Significant stress — including pregnancy, childbirth, illness, crash dieting, or bereavement — pushes large numbers of follicles into the resting phase simultaneously, causing widespread shedding 2–4 months later.
Traction Alopecia
Particularly common in women who wear tight hairstyles (braids, weaves, high ponytails) regularly. Hair is lost along the hairline and temples initially, and can become permanent if traction is prolonged.
The Ludwig Scale: Classifying Female Hair Loss
Mild thinning at the crown — most visibly expressed as a widening of the central parting. The frontal hairline is preserved. Most apparent when the hair is parted in the middle.
Clearly visible diffuse thinning at the crown. Scalp may be visible through hair when parted. Ponytails feel noticeably thinner. Most common stage at which women present for consultation.
The scalp is clearly visible across much of the crown. Most advanced stage of FPHL. Requires comprehensive treatment — both surgical and medical.
Hormonal Causes of Female Hair Loss
PCOS (Polycystic Ovary Syndrome)
PCOS affects 5–15% of women of reproductive age. Characterised by elevated androgens, insulin resistance, and irregular periods. Elevated androgens directly drive female pattern hair loss — often causing significant thinning in women in their 20s and 30s. Effective management of PCOS is a critical component of treating PCOS-related hair loss.
Menopause & Perimenopause
The dramatic decline in oestrogen and progesterone during perimenopause and menopause removes their hair-protective effects — allowing androgens to exert greater influence on susceptible follicles. Many women first notice significant hair thinning in their 40s and 50s.
Postpartum Hair Loss
During pregnancy, elevated oestrogen prolongs the hair growth phase. After delivery, oestrogen plummets, triggering synchronised entry of many follicles into the resting phase — causing significant shedding typically beginning 2–4 months postpartum. This affects up to 90% of women and is entirely normal. The vast majority recover full density within 12–18 months.
Thyroid Dysfunction
Both hypothyroidism and hyperthyroidism cause diffuse hair loss. Thyroid dysfunction is particularly common in Indian women. Hair loss from thyroid conditions typically resolves once thyroid levels are normalised, though this may take 6–12 months.
Treatment Options for Female Hair Loss
Medical Treatments
- Minoxidil (topical 5% or oral 0.5–2.5mg): First-line treatment for FPHL. Oral minoxidil increasingly preferred for superior convenience and efficacy. Takes 3–6 months; must be continued to maintain benefit.
- Spironolactone (50–200mg daily): Anti-androgen particularly effective for PCOS-related FPHL. Blocks androgen receptors and reduces DHT activity at the follicle level.
- Combined oral contraceptives: Low-androgen pills (drospirenone-containing) can help manage androgen-driven FPHL in suitable women.
Regenerative Treatments
- PRP Therapy: Highly effective for early-stage FPHL and telogen effluvium. 4–6 sessions recommended, followed by maintenance every 6 months.
- GFC Therapy: Superior to PRP in growth factor concentration — often preferred for women who have not responded adequately to PRP alone.
- Mesotherapy: Targeted nutritional support for follicles.
DHI Hair Transplant for Women — No Shave Required
At Sapphire Roots, we offer DHI (Direct Hair Implantation) with the CHOI pen — which allows transplant in women without shaving the recipient area. Only a small, concealable donor area is shaved. DHI is ideal for Ludwig Stage II and III, frontal hairline refinement, and restoring density in the crown and parting area.
✓ No shaving of recipient area ✓ Long hair conceals procedure ✓ Ideal for diffuse thinning ✓ Higher graft survival rate ✓ Natural density within existing hair ✓ No linear scar ✓ Return to work within 5–7 days